# Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients

> **NCT04559334** · NA · SUSPENDED · sponsor: **Boston Children's Hospital** · enrollment: 15 (actual)

## Conditions studied

- Central Line Complication
- Central Line-associated Bloodstream Infection (CLABSI)

## Interventions

- **DEVICE:** Tetrasodium EDTA Catheter Lock Solution

## Key facts

- **NCT ID:** NCT04559334
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-12-21
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** There is a new randomized controlled study being coordinated at Cincinatti Children's Hospital (Paul Wales MD, Principal Investigator). Only patients enrolled in this compassionate use study can continue to participate and is closed to new patients.
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559334, "Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04559334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*